Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

James Cooper

Neurology Greenville, NC Medical Doctor

NPI 1356436745 CMS profile 15632

498A Red Banks Road, Greenville, NC 27858

Open in the dashboard

General payments

$199,790

916 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, James Cooper of Greenville, NC is reported in the CMS Open Payments database as having received $199,790 across 916 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $502 28
2022 General $31,564 193
2021 General $62,142 215
2020 General $42,855 232
2019 General $62,727 248

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Cooper
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to James Cooper were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year James Cooper Neurology median Middle half National median
2019 $62,727 $474 $118–$2,177 $163
2020 $42,855 $367 $82–$2,309 $114
2021 $62,142 $438 $104–$2,547 $132
2022 $31,564 $442 $103–$2,388 $149
2023 $502 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Amgen Inc. $67,752 164 payments
  2. Teva Pharmaceuticals USA, Inc. $44,594 105 payments
  3. AbbVie, Inc. $43,917 85 payments
  4. Biohaven Pharmaceuticals, Inc. $15,889 33 payments
  5. Allergan Inc. $14,578 50 payments
  6. Upsher-Smith Laboratories LLC $4,212 17 payments
  7. Biohaven Pharmaceutical Holding Company Ltd. $2,592 16 payments
  8. Novartis Pharmaceuticals Corporation $735 61 payments
  9. Amneal Pharmaceuticals LLC $557 41 payments
  10. Genzyme Corporation $547 35 payments
  11. Other $4,417 309 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $174,219 104 payments
  2. Food and Beverage $16,728 770 payments
  3. Travel and Lodging $7,489 36 payments
  4. Consulting Fee $1,150 2 payments
  5. Education $205 4 payments
Products named General payments · program years 2019–2023
  1. AIMOVIG $68,209 205 payments
  2. UBRELVY Neuroscience $44,172 74 payments
  3. AJOVY Central Nervous System $26,638 52 payments
  4. NURTEC ODT $18,481 49 payments
  5. Ajovy Central Nervous System $17,692 38 payments
  6. UBRELVY Neuroscience $13,973 30 payments
  7. TOSYMRA $4,080 9 payments
  8. ZEMBRACE SYMTOUCH $4,080 9 payments
  9. RYTARY $557 41 payments
  10. TROKENDI XR $487 48 payments
  11. Other $6,250 433 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

916 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record